Researchers suggest that a progranulin-derived protein could result in alternative treatments for people with chronic autoimmune diseases such as rheumatoid arthritis, Crohn's diseases, ulcerative colitis, ankylosing spondylitis, plaque psoriasis and psoriatic arthritis. A study was published in the March 10, 2011 issue of Science.
The scientists at NYU Langone Medical Center, created a molecule called ATSTTRIN and used it in this study published online 10 March 2011 in Science magazine - The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice
The scientists at NYU Langone Medical Center, created a molecule called ATSTTRIN and used it in this study published online 10 March 2011 in Science magazine - The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice
No comments:
Post a Comment